This paper examines the drivers behind India's sustained economic growth, focusing on three foundational factors: investment in education, infrastructure development, and government policies reducing tariffs on foreign direct investment. It explores how these elements have positioned India as a global leader in software and pharmaceuticals, and considers the challenges multinational corporations face when expanding into Indian consumer markets through FDI strategies, including cultural sensitivity, regulatory navigation, and local supply chain development.
The paper uses a cause-and-effect structure effectively: it establishes long-term policy decisions as causes and traces their observable economic outcomes as effects. This technique is reinforced by citing sector-level evidence (IT outsourcing, pharmaceutical R&D) to substantiate the broader macroeconomic claim, moving from general to specific in a disciplined way.
The paper opens with a macroeconomic overview and thesis statement identifying three growth drivers. The second paragraph narrows to sectoral evidence in IT and pharmaceuticals. The third and final paragraph pivots to forward-looking analysis of FDI opportunities and the cultural and regulatory hurdles MNCs must overcome. This three-paragraph structure mirrors an introduction–evidence–implication framework common in short analytical essays.
India's economy continues to grow at one of the most rapid rates in the world (Shroff, 2008), with the Gross National Product (GNP) expanding at a consistent rate of 6% or more per year. The catalyst of this economic growth has been investment in education, infrastructure, and favorable tariffs applied to information technology and high-technology sectors. These three factors — education, infrastructure investment, and the Indian government's approach to lowering tariffs on Foreign Direct Investment (FDI) — have combined over the last twenty years to create the foundation for the economic growth India is experiencing today (Chakraborty & Nunnenkamp, 2008).
India is developing particular strength in software and pharmaceuticals as a direct result of the country's long-term investments in these foundational areas. Specifically, the country's decision to concentrate on developing world-class university programs in engineering, sciences, and technology has prompted other nations to outsource work to Indian firms. The Indian impact on the worldwide software industry clearly demonstrates how a twenty-year investment in education has transformed the country into a global leader in IT (Aggarwal, 2008). The same dynamic holds true in pharmaceuticals, where companies worldwide are increasingly turning to India for the research and development of new drug treatments.
You’re 42% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.